Read the full story here: What GLP1 users need: Food, nutrition and CPG innovation Nestl signals strategic reset in a shifting market The last month marked a critical moment for Nestl, as its CEO Phillip Navratil outlined a broader strategic overhaul aimed at sharpening focus, restoring growth and responding to changing consumer demand
Buyers send samples, vendors post the certificates, group buys get tested batch by batch
This precision approach helps prioritize which strategiesdietary, behavioral, or pharmacologicalalign best with individual biology
SURMOUNT studied it for weight management (published in The New England Journal of Medicine , 2022), and SURMOUNT-OSA addressed obstructive sleep apnea (NEJM, 2024)
Shift to Another Medication (like Tirzepatide) Patients who plateau or cant access Ozempic often transition to GLP-1/GIP therapy for continued progress
No Safety Evidence for the Proposed Subcutaneous Route FDA reported that it did not identify safety data for emideltide free base or emideltide acetate administered through the nominated subcutaneous route
